SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-044160
Filing Date
2013-08-09
Accepted
2013-08-09 08:30:34
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT v349735_10q.htm 10-Q 627396
2 EXHIBIT 3.1 v349735_ex3-1.htm EX-3.1 64542
3 CERTIFICATION v349735_ex31-1.htm EX-31.1 9547
4 CERTIFICATION v349735_ex31-2.htm EX-31.2 10161
5 CERTIFICATION v349735_ex32-1.htm EX-32.1 6789
  Complete submission text file 0001144204-13-044160.txt   6494057

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT anip-20130630.xml EX-101.INS 711142
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE anip-20130630_cal.xml EX-101.CAL 46801
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE anip-20130630_def.xml EX-101.DEF 184694
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE anip-20130630_lab.xml EX-101.LAB 287666
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anip-20130630_pre.xml EX-101.PRE 232064
11 XBRL TAXONOMY EXTENSION SCHEMA anip-20130630.xsd EX-101.SCH 40648
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31812 | Film No.: 131024548
SIC: 2834 Pharmaceutical Preparations